+Search query
-Structure paper
Title | Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1-Nrf2 PPI Inhibitor. |
---|---|
Journal, issue, pages | Acs Med. Chem. Lett., Vol. 14, Page 658-665, Year 2023 |
Publish date | Mar 27, 2023 (structure data deposition date) |
Authors | Otake, K. / Ubukata, M. / Nagahashi, N. / Ogawa, N. / Hantani, Y. / Hantani, R. / Adachi, T. / Nomura, A. / Yamaguchi, K. / Maekawa, M. ...Otake, K. / Ubukata, M. / Nagahashi, N. / Ogawa, N. / Hantani, Y. / Hantani, R. / Adachi, T. / Nomura, A. / Yamaguchi, K. / Maekawa, M. / Mamada, H. / Motomura, T. / Sato, M. / Harada, K. |
External links | Acs Med. Chem. Lett. / PubMed:37197451 |
Methods | X-ray diffraction |
Resolution | 1.48 - 1.8 Å |
Structure data | PDB-8ivg: PDB-8ivr: PDB-8ixs: |
Chemicals | ChemComp-SGO: ChemComp-DTT: ChemComp-SO4: ChemComp-HOH: ChemComp-SIU: ChemComp-T6I: |
Source |
|
Keywords | PEPTIDE BINDING PROTEIN / chronic kidney disease (CKD) / Keap1 / Nrf2 / non-covalent inhibitor |